AS9941 RANBAXY-IN-AS Ranbaxy Laboratories Limited

AS9941 (RANBAXY-IN-AS) is registered to Ranbaxy Laboratories Limited, the Indian generic-pharmaceuticals manufacturer. It is a corporate enterprise AS, not a service provider: the company took an ASN and portable address space so its own sites could be multihomed across more than one Indian carrier.

What it's used for

The routing footprint is that of a single enterprise, and nothing more. RIS sees one IPv4 prefix — 202.62.116.0/23, 512 addresses — no IPv6, and 2 observed neighbours. Two upstreams and one prefix is textbook enterprise multihoming: the AS exists solely so that one block of company address space can be reached over either transit provider if one fails, which is the only reason a pharmaceutical manufacturer would ever need to speak BGP.

The APNIC records back this up. The inetnum netname is RANBAXYIN, described in the registry as "Ranbaxy Laboratories Limited, Pharmaceuticals Major, India", and route objects for the /23 and its two /24s are registered directly by Ranbaxy under MAINT-IN-RANBAXY alongside proxy-registered objects from Indian and international carriers (REACH, VSNL, Level 3) that have carried the space at various points.

Notable

• Ranbaxy was acquired by Sun Pharmaceutical Industries in a deal announced in 2014 and completed in March 2015, and ceased to exist as an independent company. The ASN and address space still carry the Ranbaxy name in the registry — a common outcome, since corporate network records are rarely renamed after a merger even when the operating entity is gone.
• A 512-address enterprise block is small even by corporate standards, which fits: the routed space is for internet-facing and remote-access infrastructure, not for a large internal estate, which will be on RFC1918 space behind it.